Skip to main content
. Author manuscript; available in PMC: 2018 Dec 15.
Published in final edited form as: Sex Transm Infect. 2018 Mar 21;94(6):414–420. doi: 10.1136/sextrans-2017-053376

Table 3.

Factors associated with endometrial Mycloplasma genitalium infection

Risk factor* Cervix only
n=20
Endometrial
n=19
RR (95%CI) P values RRadj (95%CI) P values
Demographics and behaviour
 Age 21±3.1 21±2.4 1.0 (0.9 to 1.1) 0.85 NA NA
 Non-black race 9 (45.0) 3 (15.8) 0.4 (0.2 to 1.2) 0.10 0.7 (0.3 to 1.4)§ 0.31
 Uninsured Reference Reference Reference
  Private insurance 2 (10.0) 3 (15.7) 0.9 (0.4 to 2.1) 0.89 NA NA
  Medicaid 12 (60.0) 11 (57.9) 1.2 (0.5 to 2.8) 0.57 NA NA
 Posthigh school education Reference Reference Reference NA NA
  <High school education 4 (20.0) 5 (26.3) 1.0 (0.5 to 2.6) 0.96 NA NA
  High school education 9 (45.0) 8 (42.1) 1.2 (0.5 to 2.6) 0.66
 Married 2 (10.0) 2 (10.5) 1.0 (0.4 to 2.9) 0.97 NA NA
 Non-smoker 10 (50.0) 5 (26.3) 0.6 (0.3 to 1.3) 0.16 0.7 (0.4 to 1.4)§ 0.34
 Drug user 5 (25.0) 9 (47.4) 1.6 (0.9 to 3.0) 0.13 1.0 (0.4 to 2.5) 0.97
 Douching 9 (45.0) 9 (47.3) 1.1 (0.5 to 1.9) 0.88 NA NA
Reproductive history, sexual activity and contraception
 History of Chlamydia trachomatis 11 (55.0) 5 (26.3) 0.5 (0.2 to 1.1) 0.10 0.8(0.4 to 1.7) 0.59
 History of Neisseria gonorrhoeae 7 (35.0) 4 (21.0) 0.7 (0.3 to 1.6) 0.37 NA NA
 History of Trichomonas vaginalis 4 (20.0) 2 (10.5) 0.5 (0.1 to 3.1) 0.48 NA NA
 History of BV 10 (50.0) 7 (36.8) 0.6 (0.2 to 2.2) 0.43 NA NA
 Female partner 3 (15.0) 6 (31.5) 1.6 (0.9 to 3.0) 0.11 1.2 (0.6 to 2.2) 0.60
 Infected partner 6 (30.0) 5 (26.3) 0.8 (0.2 to 3.4) 0.81 NA NA
 Multiple partners 3 (15.0) 3 (16.7) 1.1 (0.2 to 6.0) 0.94 NA NA
 New partner 30d 5 (25.0) 4 (21.1) 0.8 (0.2 to 3.7) 0.79 NA NA
 Oral sex 15 (65.2) 10 (52.6) 0.6 (0.3 to 1.2) 0.13 0.6 (0.3 to 0.9)§ 0.04
 Consistent condom use Reference Reference Reference NA NA
  Rarely/never use condoms 5 (25.0) 3 (16.7) 0.5 (0.1 to 2.5) 0.38
  Inconsistent condom use 7 (35.0) 5 (26.3) 0.5 (0.1 to 2.3) 0.41
 Depo-Provera injections 3 (15.0) 4 (21.1) 1.2 (0.6 to 2.5) 0.59 NA NA
 Withdrawal 8 (40.0) 6 (31.5) 0.7 (0.2 to 2.6) 0.61 NA NA
 None 3 (15.0) 3 (16.7) 1.1 (0.2 to 6.0) 0.95 NA NA
Microbiology
C. trachomatis
  None Reference Reference Reference
  Cervical 16 (80.0) 13 (68.4) 0.7 (0.4 to 1.4) 0.38 NA NA
  Endometrial 2 (10.0) 8 (42.1) 2.1 (1.2 to 3.7) 0.009 1.7(1.1 to 2.8)§ 0.02
N. gonorrhoeae 3 (15.0) 2 (11.1) 0.7 (0.1 to 4.8) 0.73 NA NA
BV 15 (75.0) 13 (68.4) 2.8 (0.6 to 12.3) 0.17 1.5 (0.7 to 2.8) 0.27
T. vaginalis 2 (10.0) 8 (42.1) 2.1 (1.2 to 3.7) 0.009 2.0 (1.2 to 3.4)§ 0.01
 High bacterial burden** 10 (50.0) 16 (84.2) 2.4 (0.9 to 6.8) 0.08 2.3 (1.0 to 5.2)§ 0.05
*

Factors with cell size <2 were not analysed. This included some contraception methods (pills and IUD) and sexual activity variables (uncircumcised partner, anal sex, etc and so on).

P≤0.2 in univariable analyses were tested in the multivariable analysis, where variables with a P≤0.1 were retained.

Age is a continuous variable, values listed in table are mean±SD. All others are binary or categorical and listed as n (%).

§

Included in final model.

Not retained in the final model.

**

High burden >104 DNA copies/swab.

BV, bacterial vaginosis; IUD, intrauterine device.